17q gain in neuroblastoma predicts adverse clinical outcome

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

1998 • 190 citations

Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.

1997 • 185 citations

Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma

1995 • 174 citations

I;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines

1994 • 153 citations

Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization

1998 • 138 citations

Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients

1997 • 111 citations

Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.

1994 • 111 citations

COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGY

1997 • 106 citations

Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas

1996 • 100 citations

Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.

1997 • 93 citations

Comparative genomic hybridization study of primary neuroblastoma tumors

1997 • 73 citations

Promiscuous translocations of chromosome arm 17q in human neuroblastomas

1997 • 62 citations

Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines

1998 • 38 citations

Cited By (0)

Loading...